Small study tests best epinephrine dose for kids in crisis
NCT ID NCT05327556
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study compared two different doses of epinephrine (0.5 vs 1.0 mcg/kg) given to children in the intensive care unit for life-threatening low blood pressure. The goal was to see which dose raised blood pressure more effectively. Only 15 children were enrolled before the study was stopped early.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- epinephrine
- What this could lead to
- If successful, this could help doctors choose the best dose of epinephrine to quickly raise blood pressure in critically ill children.
- What could go wrong
- This was a very small, early-phase trial that was terminated early, so results are limited. It only looked at short-term blood pressure changes, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
15 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Up to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male or female less than 26 years of age. 2. Admitted to BCH and receiving care in a participating ICU. 3. Is prescribed BDE for acute hypotension deemed to be life-threatening in the judgement of the treating clinician. Exclusion Criteria: 1. Has opted out of the study prior to enrollment. 2. Has orders in place which limit resuscitation efforts. 3. Is actively receiving chest compressions while PBE is administered. 4. Is receiving care in the neonatal intensive care unit. 5. Is receiving care outside of the ICU at the time PBE is administered (i.e procedural areas). 6. Is pregnant or breastfeeding. 7. Is a prisoner. 8. Is a ward if the state (DCF custody).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hypotension are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a slower oxytocin infusion prevent dangerous blood pressure drops in C-Sections?
- Spinal stimulation may tame blood pressure swings after injury
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?
- Can a Light-Guided device make arterial sticks easier?
- Can a simple pill stabilize blood pressure after spinal cord injury?
- Can a smart pump prevent dangerous drops in blood pressure during C-Sections?